UBS’s Osiris Therapeutics OSIR Stock Holding History
Bought
Maintained
Sold
Other funds holding OSIR
BBA
UBS's OSIR Position: Q3 2014 in Review
UBS increased its Osiris Therapeutics (OSIR) stake by 512% in Q3 2014, buying an estimated $117K and bringing the position to 9,799 shares worth $123K. The position accounts for ﹤0.01% of the portfolio, ranked #5755.
UBS first reported a position in OSIR in Q2 2013 and has held it in 6 quarters since. The position peaked at $292K in Q3 2013. 67 funds tracked by Wall St. Rank hold OSIR as of Q3 2014.
- UBS held 9,799 shares of Osiris Therapeutics worth $123K as of Q3 2014.
- UBS bought 8,199 Osiris Therapeutics shares in Q3 2014, an estimated $117K.
- Osiris Therapeutics made up ﹤0.01% of UBS's portfolio in Q3 2014, its #5755 holding.
- UBS first reported a position in Osiris Therapeutics in Q2 2013 and has held it in 6 quarters since.
- UBS's Osiris Therapeutics position peaked at $292K in Q3 2013.
- 67 funds tracked by Wall St. Rank held Osiris Therapeutics as of Q3 2014.
Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.